{"id":"control-live-attenuated-mumps-vaccine","safety":{"commonSideEffects":[{"rate":"null","effect":"Injection site pain"},{"rate":"null","effect":"Fatigue"},{"rate":"null","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This immune response helps the body recognize and fight the mumps virus, providing protection against the disease. The vaccine is made from a weakened form of the virus, which cannot cause the disease but still triggers an immune response.","oneSentence":"The control live attenuated mumps vaccine works by introducing a weakened form of the mumps virus to stimulate an immune response.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:07:36.139Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of mumps"}]},"trialDetails":[{"nctId":"NCT07103148","phase":"PHASE3","title":"A Phase III Control Study of the Safety and Immunogenicity of vYF in Pediatric Population","status":"RECRUITING","sponsor":"Sanofi","startDate":"2025-07-11","conditions":"Yellow Fever Immunization","enrollment":2440},{"nctId":"NCT06397768","phase":"PHASE3","title":"Co-administration Study of an Investigational Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers","status":"TERMINATED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2024-05-13","conditions":"RSV Immunization","enrollment":2226},{"nctId":"NCT06399003","phase":"PHASE3","title":"Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months","status":"COMPLETED","sponsor":"Shanghai Institute Of Biological Products","startDate":"2024-06-28","conditions":"Measles-Mumps-Rubella","enrollment":1200},{"nctId":"NCT04475081","phase":"PHASE3","title":"Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis","status":"COMPLETED","sponsor":"Louisiana State University Health Sciences Center in New Orleans","startDate":"2020-09-22","conditions":"Sepsis Syndrome","enrollment":50},{"nctId":"NCT03133923","phase":"PHASE2","title":"Phase II of Live Attenuated Mumps (F-genotype) Vaccine (Human Diploid Cell, KMB-17) in Chinese Infants","status":"UNKNOWN","sponsor":"Institute of Medical Biology, Chinese Academy of Medical Sciences","startDate":"2017-05-20","conditions":"Epidemic Parotitis,Mumps","enrollment":1080},{"nctId":"NCT05065177","phase":"PHASE3","title":"Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants","status":"COMPLETED","sponsor":"Sinovac Research and Development Co., Ltd.","startDate":"2016-01","conditions":"Mumps","enrollment":1140},{"nctId":"NCT04111432","phase":"PHASE4","title":"Safety and Immunogenicity of Concomitant Administration of EV71 Vaccine With Expanded Programme on Immunization Vaccines","status":"COMPLETED","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2019-07-26","conditions":"Hand, Foot and Mouth Disease","enrollment":372},{"nctId":"NCT02692599","phase":"PHASE3","title":"Safety and Immunogenicity Study of Live Attenuated Mumps Vaccines in Healthy Infants","status":"COMPLETED","sponsor":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","startDate":"2016-01","conditions":"Mumps","enrollment":1150},{"nctId":"NCT00127023","phase":"PHASE3","title":"Immunogenicity and Safety of a Combined Vaccine to Prevent Measles, Mumps, Rubella and Chickenpox Diseases","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-05","conditions":"Mumps, Varicella, Rubella","enrollment":944},{"nctId":"NCT01064141","phase":"PHASE2","title":"A Study of Dengue Vaccine in Healthy Toddlers Aged 12 to 15 Months in the Philippines","status":"COMPLETED","sponsor":"Sanofi","startDate":"2010-01","conditions":"Dengue Fever, Dengue Hemorrhagic Fever","enrollment":210}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":12,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"control live attenuated mumps vaccine","genericName":"control live attenuated mumps vaccine","companyName":"Sinovac Research and Development Co., Ltd.","companyId":"sinovac-research-and-development-co-ltd","modality":"Biologic","firstApprovalDate":"","aiSummary":"The control live attenuated mumps vaccine works by introducing a weakened form of the mumps virus to stimulate an immune response. Used for Prevention of mumps.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}